ENSYSCE BIOSCIENCES, INC. Shareholders' Equity
ENSYSCE BIOSCIENCES, INC. (ENSC) had Shareholders' Equity of -$781.70 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity Attributable to Parent -$781.70K.
- 2026-03-31: Stockholders' Equity Attributable to Parent -$340.04K.
- 2025-12-31: Stockholders' Equity Attributable to Parent $3.21M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $1.20M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | -$781.70K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | -$340.04K 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $3.21M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $1.20M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $3.39M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $3.05M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $3.71M 10-K · filed 2026-03-30 | |
| 2024-09-30 | $6.91M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $1.81M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $3.75M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | -$322.86K 10-K · filed 2025-03-10 | |
| 2023-09-30 | $1.49M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $4.12M 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $166.72K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | -$3.71M 10-K · filed 2024-03-15 | |
| 2022-09-30 | -$6.09M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | -$491.64K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $1.39M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | -$7.88M 10-K · filed 2023-03-30 | |
| 2021-09-30 | -$105.69K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $5.41M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $1.89M 10-Q · filed 2021-06-08 | |
| 2020-12-31 | -$6.44M 10-K · filed 2022-03-31 | $5.00M 10-K · filed 2021-03-15 |
| 2020-09-30 | $1.52M 10-K/A · filed 2021-06-08 | $5.00M 10-Q · filed 2020-11-09 |
| 2020-06-30 | -$2.69M 10-K/A · filed 2021-06-08 | $5.00M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $4.52M 10-K/A · filed 2021-06-08 | $5.00M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $5.00M 10-K/A · filed 2021-06-08 | |
| 2019-09-30 | $5.00M 10-K/A · filed 2021-06-08 | |
| 2019-06-30 | $5.00M 10-K/A · filed 2021-06-08 | |
| 2019-03-31 | $5.00M 10-K/A · filed 2021-06-08 | |
| 2018-12-31 | $5.00M 10-K/A · filed 2021-06-08 | |
| 2018-09-30 | $5.00M 10-K/A · filed 2021-06-08 | |
| 2018-06-30 | $5.00M 10-K/A · filed 2021-06-08 | |
| 2018-03-31 | $5.00M 10-K/A · filed 2021-06-08 | |
| 2017-12-31 | $5.00M 10-K/A · filed 2021-06-08 | |
| 2017-12-05 | $5.00M 10-K/A · filed 2021-06-08 | |
| 2017-09-30 | $20.00K 10-Q · filed 2018-01-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |